まとめ
細胞毒性Tリンパ球 (CTLs) は,標的細胞を破壊するために,表面上の特定のT200タンパク質の改変を利用します. これらの変異は,活性化されたT細胞に限定され,CTL機能にとって極めて重要であり,抗体によって阻害され得る.
科学分野:
- 免疫学 免疫学とは
- 細胞生物学 細胞生物学
背景:
- 細胞毒性Tリンパ球 (CTLs) のプラズマ膜グリコプロテインは,標的細胞の結合と破壊を媒介する.
- 異なる表面タンパク質プロファイル,特に高分子量 (Mr) タンパク質は,成熟したCTLをナイブまたは非細胞分解性T細胞と区別し,活性化または溶解における役割を示唆しています.
研究 の 目的:
- 細胞毒性Tリンパ球 (CTLs) の高Mr膜タンパク質の特定の改変を調査する.
- T細胞活性化と細胞分解機能に関与するCTL固有の表面タンパク質変異を特定する.
主な方法:
- CTLクローンの細胞表面タンパク質に対するモノクローナル抗体の生成.
- ネオアンチゲン決定因子のモノクローナル抗体認識を用いたT200タンパク質改変の分析.
- 細胞分解活性に対する抗体阻害の評価.
主要な成果:
- CTLは,T200膜タンパク質に特異的な変化を示す.
- これらのT200新抗原的決定因子は,活性化されたT細胞にのみ存在し,CTL細胞に高濃度で存在します.
- これらの新型エピトープを標的にする抗体は,CTL媒介の細胞分解活性を阻害する.
結論:
- T200タンパク質は,T細胞の活性化を示すCTL特異的な改変を経験する.
- これらの改変されたT200エピトープは,CTLsの細胞毒性機能にとって極めて重要です.
- これらの修正をターゲットにすることで,CTLの活動を調節する潜在的な戦略が提供されます.
関連する概念動画
Special Features of Adaptive Immunity
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


